SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-15-069771
Filing Date
2015-02-27
Accepted
2015-02-27 16:14:04
Documents
3
Period of Report
2015-02-26
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d880038d8k.htm 8-K 16034
2 EX-99.1 d880038dex991.htm EX-99.1 8002
3 GRAPHIC g880038g97f54.jpg GRAPHIC 15593
  Complete submission text file 0001193125-15-069771.txt   46854
Mailing Address 7555 GATEWAY BLVD. NEWARK CA 94560
Business Address 7555 GATEWAY BLVD. NEWARK CA 94560 510-742-3400
Revance Therapeutics, Inc. (Filer) CIK: 0001479290 (see all company filings)

IRS No.: 770551645 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36297 | Film No.: 15658868
SIC: 2834 Pharmaceutical Preparations